Skip to main content
. Author manuscript; available in PMC: 2023 Nov 10.
Published in final edited form as: Nat Med. 2022 Nov 10;28(11):2353–2363. doi: 10.1038/s41591-022-02047-z

Extended Data Fig. 3 |. Survival of patients without tissue sequencing matched to targeted therapy by ctDNA.

Extended Data Fig. 3 |

Kaplan-Meier survival curves for patients without tissue sequencing matched or not matched to targeted therapy. Number at risk in each category is adjusted for left truncation and time-dependent nature of targeted therapy variables.